ICU住院患者多药耐药菌感染病原菌耐药性与免疫功能分析

Distribution, drug resistance of the pathogenic bacteria and immune function of patients hospitalized in ICU with multi-drug resistant organism infection

  • 摘要: 目的 分析重症监护病房(ICU)住院患者多药耐药菌(Multi-Drug Resistent Organisms,MDRO)感染的病原菌分布、耐药性及患者的免疫功能。方法 选择2014年1月-2016年12月ICU住院患者96例为试验组,选取同期于医院体检的健康人100名设为对照组。对感染患者的病原菌、MDRO感染情况及耐药性进行分析,比较两组研究对象外周血T淋巴细胞亚群指标。结果 试验组患者发生感染26例,感染率为27.08%,感染46例次,感染部位以下呼吸道为主;共培养分离病原菌76株,其中革兰阴性菌51株占67.11%,以大肠埃希菌、鲍氏不动杆菌为主;革兰阳性菌25株占32.89%,以粪肠球菌、金黄色葡萄球菌为主;共检出40株MDRO病原菌。革兰阴性MDRO病原菌对于大多数抗菌药物具有较高的耐药率,大肠埃希菌对亚胺培南和美罗培南耐药株数较少。革兰阳性MDRO病原菌对于大多数抗菌药物具有较高的耐药率,对万古霉素、替考拉宁、利奈唑胺的耐药株数较少。试验组患者的外周血CD3+、CD4+、CD8+、CD4+/CD8+分别为(62.28±4.75)%、(33.16±5.06)%、(26.64±3.34)%和(1.28±0.29)均低于对照组(P<0.05)。结论 ICU住院患者MDRO对多数临床常用抗菌药物具有较强的耐药性,临床应给予高度重视,根据药敏结果选取敏感性抗菌药物进行治疗。

     

    Abstract: OBJECTIVE To analyze the distribution, drug resistance of the pathogenic bacteria and immune function of patients hospitalized in intensive care unit (ICU) with mult-drug resistant organism (MDRO) infection. METHODS A total of 96 cases of patients hospitalized in ICU from Jan. 2014 to Dec. 2016 were selected as the observation group, and 100 healthy people were selected as the control group. The distribution of pathogenic bacteria, the infection condition and drug resistance of MDRO in the infected patients were analyzed. The indicators of T lymphocyte subgroups in the peripheral blood of the subjects in the two groups were compared. RESULTS There were 26 cases of infections in the observation group, with the infection rate of 27.08%, and the 61 case-time were infected. The distribution of infected sites was mainly in the lower respiratory tract. Totally 76 strains of bacteria were isolated, in which, 51 strains were gram-negative bacteria accounting for 67.11%, mainly Escherichia coli and Acinetobacter baumannii, and 25 strains were gram-positive bacteria accounting for 32.89%, mainly Enterococcus faecalis and Staphylococcus aureus. A total of 40 strains of MDRO in the pathogenic bacteria were detected. The drug resistant rates of gram-negative pathogens of MDRO to most antibacterial agents were higher, and E. coli was less resistant to imipenem and meropenem. The drug resistant rates of gram-positive pathogens of MDRO to most antibacterial agents were higher, and the strains resistant to vancomycin, teicoplanin or linezolid were less. The CD3+, CD4+, CD8+ and CD4+/CD8+ in the peripheral blood of the patients in the observation group were (62.28±4.75)%, (33.16±5.06)%, (26.64±3.34)% and (1.28±0.29), which were lower than those in the control group (P<0.05). CONCLUSION The MDRO strains have strong resistances to most antibiotics in the patients hospitalized in ICU. The clinicians should pay more attention and select sensitive antibiotics for treatment according to the results of drug sensitivity test.

     

/

返回文章
返回